Related Experiment Videos
No induction of apoptosis by IFN-beta in human antigen-specific T cells
F Zipp1, M Beyer, H Gelderblom
1Department of Neurology, University Hospital Charité, Berlin, Germany.
Abstract:
Interferon (IFN)-beta, the most effective immunomodulatory treatment for MS, inhibits the proliferation of myelin-specific T cells. We report that IFN-beta moderately enhances the expression of the death receptor, CD95, at the surface of human antigen-specific T cells. However, T-cell apoptosis was not induced by IFNbeta-1a or IFNbeta-1b as assessed by caspase activity or DNA fragmentation. Immunomodulation mediated by IFN-beta does not directly involve apoptotic pathways in human T cells.
Insights
Interferon (IFN)-beta, a treatment for MS, enhances T-cell death receptor CD95 but does not directly induce T-cell apoptosis. This suggests that IFN-beta
Area of Science:
- Immunology
- Neuroimmunology
- Cell Biology
Background:
- Multiple Sclerosis (MS) is an autoimmune disease impacting the central nervous system.
- Interferon (IFN)-beta is a primary immunomodulatory therapy for MS.
- IFN-beta's mechanism involves inhibiting myelin-specific T cells.
Purpose of the Study:
- To investigate the effect of IFN-beta on T-cell apoptosis.
- To determine if IFN-beta directly induces T-cell death pathways.
Main Methods:
- Assessing CD95 (death receptor) expression on human antigen-specific T cells.
- Measuring caspase activity and DNA fragmentation to detect apoptosis.
Main Results:
- IFN-beta moderately enhanced CD95 expression on T cells.
- Neither IFNbeta-1a nor IFNbeta-1b induced T-cell apoptosis.
- Caspase activity and DNA fragmentation assays were negative for apoptosis.
Conclusions:
- IFN-beta's immunomodulatory effects in MS do not appear to directly involve T-cell apoptosis.
- Enhanced CD95 expression may play a role in T-cell regulation independent of direct cell death.